- Home
- BNTX vs ZS Comparison
BNTX vs ZS Comparison
Compare BNTX & ZS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- ZS
- Stock Information
- Founded
- BNTX 2008
- ZS 2007
- Country
- BNTX Germany
- ZS United States
- Employees
- BNTX N/A
- ZS N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- ZS EDP Services
- Sector
- BNTX Health Care
- ZS Technology
- Exchange
- BNTX Nasdaq
- ZS Nasdaq
- Market Cap
- BNTX 23.9B
- ZS 31.7B
- IPO Year
- BNTX 2019
- ZS 2018
- Fundamental
- Price
- BNTX $121.72
- ZS $211.99
- Analyst Decision
- BNTX Strong Buy
- ZS Buy
- Analyst Count
- BNTX 14
- ZS 35
- Target Price
- BNTX $141.60
- ZS $226.21
- AVG Volume (30 Days)
- BNTX 1.1M
- ZS 2.3M
- Earning Date
- BNTX 11-04-2024
- ZS 12-02-2024
- Dividend Yield
- BNTX N/A
- ZS N/A
- EPS Growth
- BNTX N/A
- ZS N/A
- EPS
- BNTX N/A
- ZS N/A
- Revenue
- BNTX $3,390,698,192.00
- ZS $2,299,023,000.00
- Revenue This Year
- BNTX N/A
- ZS $24.23
- Revenue Next Year
- BNTX N/A
- ZS $20.79
- P/E Ratio
- BNTX N/A
- ZS N/A
- Revenue Growth
- BNTX N/A
- ZS 30.77
- 52 Week Low
- BNTX $76.53
- ZS $153.45
- 52 Week High
- BNTX $131.49
- ZS $259.61
- Technical
- Relative Strength Index (RSI)
- BNTX 60.69
- ZS 60.65
- Support Level
- BNTX $112.96
- ZS $194.64
- Resistance Level
- BNTX $121.80
- ZS $212.35
- Average True Range (ATR)
- BNTX 5.01
- ZS 7.04
- MACD
- BNTX 1.07
- ZS -0.54
- Stochastic Oscillator
- BNTX 86.57
- ZS 80.10
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.